These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11030037)

  • 41. Combined serotonin syndrome and hyponatraemia caused by a citalopram-buspirone interaction.
    Spigset O; Adielsson G
    Int Clin Psychopharmacol; 1997 Jan; 12(1):61-3. PubMed ID: 9179637
    [No Abstract]   [Full Text] [Related]  

  • 42. Selective serotonin reuptake inhibitors in adolescent depression still controversial.
    Holzer L; Baumann P
    J Clin Psychopharmacol; 2007 Jun; 27(3):325-6; author reply 326. PubMed ID: 17502798
    [No Abstract]   [Full Text] [Related]  

  • 43. The use of selective serotonin reuptake inhibitors in children and adolescents with major depression.
    Scahill L; Hamrin V; Pachler ME
    J Child Adolesc Psychiatr Nurs; 2005; 18(2):86-9. PubMed ID: 15966952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical implications of selective serotonin reuptake inhibitors-selective serotonin norepinephrine reuptake inhibitors pharmacogenetics during pregnancy and lactation.
    Koren G; Ornoy A
    Pharmacogenomics; 2018 Sep; 19(14):1139-1145. PubMed ID: 30105921
    [TBL] [Abstract][Full Text] [Related]  

  • 45. May depressed and anxious patients with carcinoid syndrome benefit from treatment with selective serotonin reuptake inhibitors (SSRIs)?: findings from a case report.
    Nobels A; Geboes K; Lemmens GM
    Acta Oncol; 2016 Nov; 55(11):1370-1372. PubMed ID: 27169982
    [No Abstract]   [Full Text] [Related]  

  • 46. Therapeutic drug monitoring of escitalopram in an outpatient setting.
    Reis M; Chermá MD; Carlsson B; Bengtsson F;
    Ther Drug Monit; 2007 Dec; 29(6):758-66. PubMed ID: 18043473
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Escitalopram-associated serotonin toxicity.
    Vari G; Beckson M
    J Clin Psychopharmacol; 2007 Apr; 27(2):229-30. PubMed ID: 17414259
    [No Abstract]   [Full Text] [Related]  

  • 48. Exacerbation of panic disorder with rifampin therapy in a patient receiving citalopram.
    Kukoyi O; Argo TR; Carnahan RM
    Pharmacotherapy; 2005 Mar; 25(3):435-7. PubMed ID: 15843291
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation.
    Baumann P; Nil R; Souche A; Montaldi S; Baettig D; Lambert S; Uehlinger C; Kasas A; Amey M; Jonzier-Perey M
    J Clin Psychopharmacol; 1996 Aug; 16(4):307-14. PubMed ID: 8835706
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part II.
    Harvey AT; Preskorn SH
    J Clin Psychopharmacol; 1996 Oct; 16(5):345-55. PubMed ID: 8889906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic drug interactions with selective serotonin reuptake inhibitor (SSRI) antidepressants.
    Baker GB; Fang J; Sinha S; Coutts RT
    Neurosci Biobehav Rev; 1998 Mar; 22(2):325-33. PubMed ID: 9579322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Considerations on safety concerns about citalopram prescribing.
    Sheeler RD; Ackerman MJ; Richelson E; Nelson TK; Staab JP; Tangalos EG; Dieser LM; Cunningham JL
    Mayo Clin Proc; 2012 Nov; 87(11):1042-5. PubMed ID: 23018033
    [No Abstract]   [Full Text] [Related]  

  • 53. Citalopram: a rapid-onset selective serotonin reuptake inhibitor?
    Crow S; Daly KA; Fatemi SH; MacGraw R; Meller W
    Can J Psychiatry; 1999 Dec; 44(10):1051-2. PubMed ID: 10637688
    [No Abstract]   [Full Text] [Related]  

  • 54. Too soon to judge value of pharmacogenetic testing in selecting antidepressant.
    Thompson CA
    Am J Health Syst Pharm; 2007 Mar; 64(5):453. PubMed ID: 17322153
    [No Abstract]   [Full Text] [Related]  

  • 55. Interactive case conference. First episode: depression and panic disorder.
    Dunner DL
    CNS Spectr; 2005 Sep; 10(9):696-7. PubMed ID: 16142209
    [No Abstract]   [Full Text] [Related]  

  • 56. Meniere's disease: some patients benefit significantly from SSRIs.
    Overton M
    Aust Fam Physician; 2003; 32(1-2):8. PubMed ID: 12647651
    [No Abstract]   [Full Text] [Related]  

  • 57. Citalopram, a selective serotonin reuptake inhibitor, improves symptoms of Friedreich's ataxia.
    Rohr A; Eichler K; Hafezi-Moghadam N
    Pharmacopsychiatry; 1999 May; 32(3):113-4. PubMed ID: 10463380
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.
    Chen F; Larsen MB; Sánchez C; Wiborg O
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):193-8. PubMed ID: 15695064
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.
    Tack J; Broekaert D; Fischler B; Van Oudenhove L; Gevers AM; Janssens J
    Gut; 2006 Aug; 55(8):1095-103. PubMed ID: 16401691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Escitalopram-Induced Rash.
    Prabhakar D; Sablaban I
    Prim Care Companion CNS Disord; 2019 Jan; 21(1):. PubMed ID: 30806996
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.